2025 second_quarter Filing

Income

$50K

Filed

July 17, 2025

Lobbying Activities

Health IssuesView all

H.R. 1, One Big Beautiful Bill Act and pharmacy benefit management. Issues related to mental health. Issues related to SUPPORT Act Reauthorization. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Issues related to drug pricing. Issues related to ingredient safety.

Contacted:Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Medicare/MedicaidView all

Implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. H.R. 1, One Big Beautiful Bill Act and issues related to drug pricing. Issues related to Most Favored Nation drug pricing. H.R. 946 / S. 1862, ORPHAN Cures Act.

Executive Office of the President (EOP), Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES

Lobbyists (5)

MARY BETH SAVARY TAYLOR

GREG D'ANGELO

BRETT BAKER

RACHEL JONES HENSLER